Academisch Ziekenhuis Leiden

At Academisch Ziekenhuis Leiden, the Cardiology department is running a strong portfolio of studies in cardiovascular diseases, especially atherosclerotic cardiovascular disease, acute coronary syndromes, aortic stenosis, and venous clotting disorders. The research focuses on improving treatment effectiveness, reducing bleeding risk, and testing new approaches to prevent major heart and vessel complications.

• Testing new therapies to lower cardiovascular risk and prevent major adverse events
• Comparing treatment strategies for acute coronary syndrome and structural heart disease
• Evaluating clot-dissolving and antithrombotic approaches for vascular conditions

Several trials also look at better ways to support patients after heart procedures and to refine long-term prevention for people with high-risk lipid and vascular disease.

A major research theme at this site is oncology, with trials across solid tumors and blood cancers such as acute myeloid leukemia, diffuse large B-cell lymphoma, multiple myeloma, non-small cell lung cancer, and gastrointestinal stromal tumor. The studies are designed to test new cancer treatments, improve survival, and identify better treatment combinations before or after surgery.

• Evaluating novel cancer medicines for advanced and relapsed disease
• Comparing treatment combinations to improve response and survival
• Studying perioperative approaches for high-risk tumors and metastatic disease

The Academisch Ziekenhuis Leiden also contributes to research in rarer cancers, including uveal melanoma, sarcoma, endometrial cancer, and esophageal cancer, reflecting a broad commitment to precision cancer care.

The site is active in studies of neuromuscular and autoimmune diseases, including generalized myasthenia gravis, Duchenne muscular dystrophy, Becker muscular dystrophy, systemic sclerosis, and systemic lupus erythematosus. These trials aim to improve symptom control, slow disease progression, and protect long-term organ function.

• Testing new immune-targeted therapies for autoimmune muscle weakness
• Assessing treatments that may preserve muscle strength and function
• Exploring strategies to prevent major organ damage in systemic disease

Research in this area combines treatment innovation with a focus on everyday outcomes that matter to patients, such as mobility, strength, and quality of life.

Clinical trials at this hospital also cover transplant medicine, kidney-related care, and immunology, including studies in kidney transplantation, anti-GBM antibody disease, and vaccination responses in immunosuppressed patients. The main goal is to improve graft outcomes, immune protection, and organ function while reducing treatment-related complications.

• Evaluating therapies to improve kidney function and transplant success
• Studying immune-based treatments for severe autoimmune kidney disease
• Optimizing vaccination and infection protection in transplant recipients

This research area reflects a strong interest in balancing effective immune control with safer long-term care for vulnerable patients.

Another important field at Academisch Ziekenhuis Leiden is diagnostic and surgical innovation, with studies focused on improving how disease is detected and treated during procedures. Research includes fluorescence-guided imaging, ureter visualization, and better imaging support for cancer surgery and abdominal operations.

• Developing tools to help surgeons see tumors and critical structures more clearly
• Improving diagnostic accuracy during complex operations
• Testing imaging-based methods that may make surgery safer and more precise

These trials aim to support more accurate interventions and better surgical outcomes across oncology and other operative specialties.

The trial portfolio also includes a wide range of rare diseases and specialized conditions, such as hypoparathyroidism, partial lipodystrophy, Menière's disease, corneal transplantation, and hearing loss prevention. These studies often focus on improving disease control, protecting organ function, or reducing symptoms that strongly affect daily life.

• Testing treatments for rare endocrine and metabolic disorders
• Improving eye, ear, and transplant-related outcomes
• Evaluating supportive care approaches for chronic symptom relief

The breadth of this research shows a commitment to both common and uncommon conditions, with an emphasis on practical benefit for patients.